Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 317 Results
Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
November 8, 2012
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
September 11, 2012
Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
September 10, 2012
Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
September 7, 2012
Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
September 6, 2012
Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
July 2, 2012
Page 27 of 32